Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Aceclidin
2. Aceclidine
3. Glaucadrine
4. Glaucocare
5. Glaucostat
6. Glaucotat
1. 6109-70-2
2. Quinuclidin-3-yl Acetate Hydrochloride
3. Aceclidine (hydrochloride)
4. Aceclidine Hcl
5. 3-acetoxyquinuclidine Hydrochloride
6. Aceclidine Hydochloride
7. 1-azabicyclo[2.2.2]oct-3-yl Acetate Hydrochloride
8. 1-azabicyclo[2.2.2]octan-3-yl Acetate;hydrochloride
9. 3b22o325q6
10. (+/-)-3-acetoxyquinuclidine Hydrochloride; 3-acetoxyquinuclidine Hydrochloride
11. Einecs 228-071-5
12. C 162 D
13. Unii-3b22o325q6
14. 1-azabicyclo(2.2.2)octan-3-ol, Acetate (ester), Hydrochloride
15. Aceclidine, Hydrochloride
16. 3-quinclidinol Dl-form Acetate Hydrochloride
17. 3-quinuclidinol, Acetate (ester), Hydrochloride
18. Schembl6237805
19. Chembl4303558
20. Dtxsid30976587
21. Ccg-39134
22. Mfcd00136230
23. Ab03765
24. Ccg-220635
25. Aceclidine Hydrochloride [mart.]
26. Aceclidine Hydrochloride [who-dd]
27. Db-053792
28. Ft-0621714
29. Sw220059-1
30. A833043
31. Sr-01000597817
32. 3-quinuclidinol Dl-form Acetate Hydrochloride
33. Sr-01000597817-1
34. Q27256986
35. 3-quinuclidinol Dl-form Acetate Hydrochloride [mi]
36. 1-azabicyclo[2.2.2]octan-3-yl Acetate--hydrogen Chloride (1/1)
Molecular Weight | 205.68 g/mol |
---|---|
Molecular Formula | C9H16ClNO2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 2 |
Exact Mass | 205.0869564 g/mol |
Monoisotopic Mass | 205.0869564 g/mol |
Topological Polar Surface Area | 29.5 Ų |
Heavy Atom Count | 13 |
Formal Charge | 0 |
Complexity | 185 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Parasympathomimetics
Drugs that mimic the effects of parasympathetic nervous system activity. Included here are drugs that directly stimulate muscarinic receptors and drugs that potentiate cholinergic activity, usually by slowing the breakdown of acetylcholine (CHOLINESTERASE INHIBITORS). Drugs that stimulate both sympathetic and parasympathetic postganglionic neurons (GANGLIONIC STIMULANTS) are not included here. (See all compounds classified as Parasympathomimetics.)
Miotics
Agents causing contraction of the pupil of the eye. Some sources use the term miotics only for the parasympathomimetics but any drug used to induce miosis is included here. (See all compounds classified as Miotics.)
Global Sales Information
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?